BioMS Recognized at 2008 Scrip Awards for Major Licencing Deal »
Posted By Br1an01 12 months ago in Business & FinanceBioMS entered into a licensing and development agreement granting Eli Lilly and Company (Lilly) exclusive worldwide rights to dirucotide, for the treatment of MS, in exchange for an US$87 million upfront payment, potential development and sales milestones up to US$410 million and escalating royalties on sales.
Scrip, the leading source of global news in the biotechnology and pharmaceutical fields, announced that BioMS Medical was the recipient of the "Licensing Deal of the Year Award" at the 4th Annual Scrip Awards held in London.
Read Full Story at biomsmedical.com »
27 Views Share Story 0 Comments Report
More News
Daily Finance
Former Bank of America employee offers inside look at bank's practices
Thar's gold in them shills! Fox raps Glenn Beck's endorsement deal
Nook e-reader: First verdicts say it's not a Kindle killer, but a worthy challenger
Side effects from antipsychotic drugs on kids lead to calls for new FDA review
Staffing company stocks are a smart bet on a muddled labor market
Add a Comment
Sign In With Your Propeller Account
Please keep your comments relevant to this story.
To create a live link, simply type the URL (including http://) or email address and we will make it a live link for you. You can put up to 3 URLs in your comments. Line breaks and paragraphs are automatically converted — no need to use <p> or <br /> tags.